VolitionRx Limited (VNRX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Cameron Reynolds MBA | Founder, CEO, President & Director | 416.02k | -- | 1971 |
| Dr. Gaetan Michel Ph.D. | Chief Operating Officer | 434.35k | -- | 1973 |
| Dr. Salvatore Thomas Butera DVM | Chief Executive Officer of Volition Veterinary Diagnostics Development LLC | 328.63k | -- | 1951 |
| Mr. Terig Hughes | CFO & Treasurer | 338.74k | -- | 1970 |
| Dr. Jacob Vincent Micallef MBA, Ph.D. | Chief Scientific Officer | 571.55k | -- | 1956 |
| Mr. Nicholas Plummer | Group General Counsel | -- | -- | 1971 |
| Ms. Louise Batchelor Day | Group Chief Marketing & Communications Officer | -- | -- | 1971 |
| Mr. Gael Forterre M.B.A. | Chief Commercial Officer | -- | -- | 1981 |
| Ms. Sharon Ballesteros | U.S. Head of Quality & Development Process | -- | -- | -- |
| Dr. Andrew Retter MBBS | Chief Medical Officer | -- | -- | 1977 |
VolitionRx Limited
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 82
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally. It offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis such as sepsis; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
Corporate Governance
Upcoming Events
August 12, 2025 at 10:59 AM UTC - August 18, 2025 at 12:00 PM UTC
VolitionRx Limited Earnings Date
Recent Events
April 25, 2025 at 12:00 AM UTC
RW WD: Withdrawal of a Registration Withdrawal Request